SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-16-119213
Filing Date
2016-08-15
Accepted
2016-08-15 13:16:27
Documents
42
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q v445890_10q.htm 10-Q 221384
2 EXHIBIT 31.1 v445890_ex31-1.htm EX-31.1 9593
3 EXHIBIT 31.2 v445890_ex31-2.htm EX-31.2 9671
4 EXHIBIT 32.1 v445890_ex32-1.htm EX-32.1 4355
5 EXHIBIT 32.2 v445890_ex32-2.htm EX-32.2 4104
  Complete submission text file 0001144204-16-119213.txt   2388051

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT mbrx-20160630.xml EX-101.INS 373550
7 XBRL TAXONOMY EXTENSION SCHEMA mbrx-20160630.xsd EX-101.SCH 34387
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mbrx-20160630_cal.xml EX-101.CAL 22908
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mbrx-20160630_def.xml EX-101.DEF 189654
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbrx-20160630_lab.xml EX-101.LAB 239139
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbrx-20160630_pre.xml EX-101.PRE 213012
Mailing Address 2575 WEST BELLFORT SUITE 333 HOUSTON TX 77054
Business Address 2575 WEST BELLFORT SUITE 333 HOUSTON TX 77054 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

IRS No.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37758 | Film No.: 161831464
SIC: 2834 Pharmaceutical Preparations